Results per Page:
New clinical trials to target HER2 positive solid cancers
From Dr. Sara Hurvitz, Clinical Research Division, and colleagues
Patient stories, provider advice mark invasive lobular breast cancer awareness event
Fred Hutch experts discuss ILC’s hormonal risk factors, screening recommendations and new research
Lived experience matters: patient engagement improves cancer care, research
Nearly 15 years in, Fred Hutch Patient and Family Engagement Program continues to inform care, expands to match advocates with researchers
Dr. Heather Parsons to lead Fred Hutch’s breast cancer initiatives
Medical oncologist awarded endowed chair to study novel markers for cancer in blood serum
Testing for hereditary cancers can be a lifesaver
Some people aren’t ready yet, while others believe ‘forewarned is forearmed’ when it comes to cancer-causing genetic variants
The Beam: Understanding liver, gastrointestinal and breast cancer treatments at Fred Hutch – Proton Therapy
Drs. Smith Apisarnthanarax and Kylie Kang talk about the latest updates in these cancers and explain the importance of proton therapy when treating these areas
Whole-body MRI and cancer screening
A perspective from radiologists at Fred Hutch Cancer Center and UW Medicine
Beating cancer and protecting the heart? the hidden perks of endocrine therapy
From the Greenlee group, Cancer Prevention Program and Public Health Science Division
After a locoregional recurrence, a breast cancer patient sought out expert care at Fred Hutch
Her care team recommended protons because of her previous radiation exposure
Kuni Foundation awards $7M to drive adult oncology research forward
Vancouver, Washington-based foundation supports innovative early-stage research on new potential therapies
Current landscape of metastatic triple-negative breast cancer survival rates
From the Hurvitz Lab, Clinical Research Division
Women’s Health Initiative: Research that keeps on giving
Three decades in, longstanding ‘team science’ study continues to provide answers to health issues facing older women
New methods reveal cancer mechanism in ancient genes
Fred Hutch researchers discover that overproduction of DNA packaging material predicts aggressive brain and breast tumors, which could lead to cheaper diagnostic tests and new drug therapies
What’s new in breast cancer research? SABCS24 looks at ctDNA, AI and ‘right-sizing’ treatment
Large research symposium highlights liquid biopsies, new drug combos, shifts in surgical practice and, yes, patient voices
Playing hide-and-seek with DTCs: new CAR-T therapy reduces risk of recurrent breast cancer
From the Ghajar Lab, Human Biology and Public Health Sciences Divisions, and the Riddell Lab, Translational Science and Therapeutics Division
Surviving and thriving with metastatic breast cancer
From financial toxicity to sexual health, experts break down survival strategies for patients and caregivers dealing with ‘mets’